Medical Research News

RSS

Olympics provide an unrealized opportunity to improve global health

Given the increased interest in sports and exercise around the Olympics underway in Tokyo, events such as the Summer Games represent an unrealized opportunity to improve global health, finds a new Lancet study from the Brown School at Washington University in St. Louis.

30 Jul 2021

New understanding of the brain’s relay station could change medical treatment for brain disorders

New research shows cells gather more data than once believed inside the thalamus, a relay station of sensory and motor abilities in the brain. That could change how medicine treats schizophrenia, epilepsy and other brain disorders.

30 Jul 2021

Fellowship directors endorse the need for increasing diversity in cardiology

Underrepresented minorities remain few in number among practicing cardiologists and across cardiology fellowship training programs in the United States, with fellowship directors agreeing that increased diversity is needed in the field and is particularly necessary within graduate medical education cardiology fellowship training programs.

30 Jul 2021

Women who suffer emergent large vessel occlusion strokes less likely to receive timely care

Women are less likely than men to receive timely care for strokes caused by blockages in large vessels, known as emergent large vessel occlusion (ELVO), according to researchers with The University of Texas Health Science Center at Houston.

30 Jul 2021

Study assesses the impact of sitting time and physical activity on mental health during the pandemic

Reducing the amount of time spent sitting down should be part of public health policy following COVID-19, says a new report from a study by the University of Huddersfield.

30 Jul 2021

BNT162b2 vaccine shows high efficacy at six months

The Pfizer/BioNTech vaccine appears to be highly effective in protecting against the SARS-CoV-2 infection, including its relatively resistant beta variant B.1.351.

30 Jul 2021

Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity

A new study reports that the Johnson and Johnson vaccine against COVID-19 shows enhanced efficacy when administered to individuals with pre-existing antibodies.

30 Jul 2021

Cash vouchers provide greater incentive for COVID-19 vaccines than lotteries

A new study focuses on cash vs lottery incentives to increase the acceptance of COVID-19 vaccines among unvaccinated adults in the USA.

30 Jul 2021

Broward Health First U.S. Hospital System Using Innovative VirtaMed Laparoscopic Simulator

Broward Health Medical Center, home to the Broward Health Graduate Medical Education Simulation Lab in Fort Lauderdale, Fla., has become the first United States medical institution to receive the VirtaMed LaparoS™ surgical training simulator. This mixed reality laparoscopic simulator provides resident doctors with a simulated environment to prepare for clinical practice safely and efficiently.

From VirtaMed 30 Jul 2021

In-silico prediction of effective drug combinations for the treatment of SARS-CoV-2 infection

A new study published on the bioRxiv preprint server has developed the first computational model, i.e., a signaling network model, that can predict effective repurposed drug combinations to treat different phases of COVID-19 disease. This study has focused on identifying drugs for the treatment of early- and late-stage severe disease.

30 Jul 2021

Scientists suspect Lambda SARS-CoV-2 variant most dangerous

A new study published on the bioRxiv* preprint server used molecular phylogenetic analysis to study the evolutionary trait of the Lambda variant.

30 Jul 2021

Large nanodiscs simulate viral entry into host cells

In a paper recently uploaded to the journal Frontiers in Biotechnology by Padmanabha Das et al. (June 12th, 2020), a method of producing significantly larger homogenous nanodiscs up to 90 nm in diameter is described, and the advantages and applications of such nanodiscs are explored: better replicating the actual curvature and membrane symmetry of a real cell membrane, and allowing much larger or multiple membrane proteins to be loaded simultaneously.

30 Jul 2021

SARS-CoV-2 interacts with sialic acid cell surface glycans

In a paper recently uploaded to the journal Frontiers in Chemistry by Li et al. (July 22nd, 2021) the interaction between the SARS-CoV-2 spike protein and N-acetylneuraminic acid (NANA), the most commonly found sialic acid in humans, is investigated, finding that the molecule may act as a secondary or supplementary receptor to the virus.

30 Jul 2021

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Nanocovax is a protein subunit vaccine that contains the full-length spike stabilized by the addition of two prolines

29 Jul 2021

Study explains how SARS-CoV-2 variants differ in binding to ACE2 receptor

The current study explored ACE2-RBD interactions with four VoCs including the Alpha, Beta, Gamma, and Delta variants.

29 Jul 2021

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Scientists from the UK and US have recently investigated immunological consequences of secondary Streptococcus pneumoniae (S. pneumoniae) infection in coronavirus disease 2019 (COVID-19) patients.

29 Jul 2021

Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine

Researchers in the United States have provided important insights into the antigen-specific cellular response and evolving humoral (antibody) response to messenger RNA- (mRNA) based vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

29 Jul 2021

Study compares the impacts of various race-free equations on kidney disease diagnoses

Equations that estimate individuals' kidney function currently include an adjustment for race. A study appearing in an upcoming issue of JASN compares various race-free equations and their expected impacts on kidney disease diagnoses.

29 Jul 2021

Study supports UK’s decision to extend second COVID-19 vaccination to 12 weeks

Findings from a study conducted in the UK support the country’s decision to extend the dosing interval of coronavirus disease 2019 (COVID-19) vaccination from 3 weeks to 12 weeks in order to prioritize the first dose for those at high risk of severe disease and death.

29 Jul 2021

Research finds associations between COVID-19 and persistent cognitive deficits

Much has been learned about SARS-CoV-2, the virus that causes the novel coronavirus, since the beginning of the COVID-19 pandemic. However, questions remain about the long-term impact of the virus on our bodies and brains.

29 Jul 2021

Medical Research News

Olympics provide an unrealized opportunity to improve global health

New understanding of the brain’s relay station could change medical treatment for brain disorders

Fellowship directors endorse the need for increasing diversity in cardiology

Women who suffer emergent large vessel occlusion strokes less likely to receive timely care

Study assesses the impact of sitting time and physical activity on mental health during the pandemic

BNT162b2 vaccine shows high efficacy at six months

Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity

Cash vouchers provide greater incentive for COVID-19 vaccines than lotteries

Broward Health First U.S. Hospital System Using Innovative VirtaMed Laparoscopic Simulator

In-silico prediction of effective drug combinations for the treatment of SARS-CoV-2 infection

Scientists suspect Lambda SARS-CoV-2 variant most dangerous

Large nanodiscs simulate viral entry into host cells

SARS-CoV-2 interacts with sialic acid cell surface glycans

Phase 1/2 trial results for Nanocovax, protein subunit SARS-CoV-2 vaccine from Vietnam

Study explains how SARS-CoV-2 variants differ in binding to ACE2 receptor

Streptococcus pneumoniae modulates host immunity to SARS-CoV-2

Study reveals cellular basis of antigen-specific response to Pfizer-BioNTech’s COVID-19 vaccine

Study compares the impacts of various race-free equations on kidney disease diagnoses

Study supports UK’s decision to extend second COVID-19 vaccination to 12 weeks

Research finds associations between COVID-19 and persistent cognitive deficits

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News